Cancer therapy-related cardiac dysfunction (CTRCD) is when the heart's ability to pump oxygenated blood to the body is compromised. It is a side effect of canc…

Heart FailureCardiotoxicityCardiac Toxicity+2 more

~Estimated

~$10 – $7,500

Dinesh ThavendiranathanNCT06183437

Phase 2

STACIE: Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted Therapy

This study proposes that the addition of statins reduces the treatment delays or early discontinuations secondary to cardiotoxicity in patients with Stage I-II…

Cardiac ToxicityEarly-stage Breast Cancer

~Estimated

~$10 – $6,250

Rutgers, The State University of New JerseyNCT05559164